OBR Daily Commentary

forumImage

Red Wine 'Can Help Breast Cancer Chemo Patients'

(The Telegraph UK) Feb 15, 2011 - Women who are about to undergo chemotherapy for breast cancer should drink a glass or two of red wine a day, research suggests.

Read Article arrow

Thomas Marsland, MD (Posted: February 16, 2011)

quotesWonder if Parker rating makes any difference cab anyone???quotes

Add Comment 1 Comment
forumImage

Health Law Provision Raises Antitrust Concerns

(New York Times) Feb 8, 2011 - The new health care law encourages collaboration by doctors and hospitals for cost savings, but a split has developed here as to just how far they can go without running afoul of antitrust laws.

Read Article arrow

Thomas Marsland, MD (Posted: February 10, 2011)

quotesThe environment is changing. Clearer guidance from Trade Commission and Federal government is certainly needed. The need for physician groups to work together and better coordinate care is truly critical to the success of any meaningful health reform. To do this provider groups need some protection from traditional antitrust provisions. Accountable care organizations and clinically integrated networks offer great opportunities to provide coordinated cost effective care. The concept is to proactively develop and provide quality and cost conscious treatment pathways that require a high degree of communication and coordination amongst providers that historically are not part of one "financially" integrated practice. In the past this may have run afoul of some antitrust issues. To develop these programs we need clear guidance on what is acceptable and what is not. quotes

Add Comment 1 Comment
forumImage

Roche’s Avastin Plus Chemotherapy Linked to Fatal Side Effects

(Bloomberg) Feb 1, 2011 - Roche Holding AG’s Avastin may increase a cancer patient’s risk of having a fatal reaction to treatment when it is added to chemotherapy, researchers said.

Read Article arrow

Thomas Marsland, MD (Posted: February 04, 2011)

quotesIt often bothers me to see this type of report in the lay press. The general public really has a poor understanding of the concept of risk and benefits. Almost all oncology drugs have the potential for toxic deaths. We have been dealing with this for a long time. Avastin is a great drug and has helped to prolong life for many patients. I would hate to see limits and restrictions put on this drug based on emotional issues. The Avastin lethal side effects (pulmonary hemorrhage, perforation, and the infections discussed were probably more from the cytotoxics) are well-known and documented and with good patient selection really are quite minimal. Certainly frank discussions need to be held with the patients. I hope a good drug doesn't become branded because of this somewhat sensationalist press... quotes

Add Comment 1 Comment

Meet the Editorial Board

Prostate Cancer
member photo
Tomasz M. Beer, MD, FACP

Professor of Medicine, Division of Hematology/Medical O...

Community Oncology
member photo
Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology...

Breast Cancer
member photo
Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncol...

Lung Cancer
member photo
H. Jack West, MD

Medical Director, Thoracic Oncology Program, Swedish Ca...

Gastrointestinal Cancers
member photo
Howard S. Hochster, MD

Distinguished Professor of Medicine, Rutgers Robert Woo...

Radiation Oncology
member photo
Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics
Pr...

Community Oncology
member photo
Jeff Patton, M.D.

CEO Tennessee Oncology...

Precision Medicine Section Editor
member photo
Jennifer Levin Carter, MD, MPH

Chief Medical Officer and Founder, N-of-One...

Financial Sector
member photo
Michael G. King Jr.

Managing Director and Senior Biotechnology Analyst...

Gastrointestinal Cancers
member photo
Richard Goldberg, MD

Director WVU Cancer Institute Director of Cancer Signa...

Editor-In-Chief
member photo
Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology...

Health Policy
member photo
Ted Okon

Executive Director Community Oncology Alliance...

Community Oncology
member photo
Thomas Marsland, MD

Vice President Integrated Community Oncology Network ...

Community Oncology
member photo
William Harwin MD

Florida Cancer Specialists President and Managing Part...

Health Policy
member photo
William McGivney, PhD

National Health Policy Expert...

Payer
member photo
Winston Wong, PharmD

President, W-Squared Group...